FDA Inspection 560541 — Syntho Pharmaceuticals, Inc.

Syntho Pharmaceuticals, Inc. — FEI 3003407422

The FDA completed an inspection of Syntho Pharmaceuticals, Inc. on Feb 3, 2009 in Farmingdale, NY. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Feb 3, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Farmingdale, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.